B+
Bull case
20%
Probability
Target price
$115.50
+80.8% vs current
BBIO
BridgeBioCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
60%
Probability
Target price
$85.79
+34.3% vs current
B-
Bear case
20%
Probability
Target price
$42.63
-33.3% vs current
AI sentiment snapshot
Latest data as of 2026-01-19
Recent news sentiment (30D)
-
Unavailable
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Sentiment proxy
+79.4
Score
AI commentary
Sentiment is cautiously constructive: analyst median sits in the mid-$80s while highs/lows are dispersed, reflecting binary clinical risk. Near-term volatility likely around corporate updates and readouts.
RankAlpha Sentiment AI - 2026-01-19
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-04-19catalystQuarterly results & analyst updatesHigh impact
Quarterly report and ensuing analyst revisions could reset guidance; consensus band reflects binary program outcomes.
2026-07-18eventClinical readouts (lead programs)High impact
Interim or pivotal readouts from lead programs may produce large directional moves; date set conservatively to the disclosed window end.
2027-01-19catalystRegulatory, partnering & financing developmentsHigh impact
Regulatory decisions, partnerships, or financing events over 12 months can meaningfully re-rate valuation; analyst dispersion highlights optionality risk/reward.
Recommendation
N/A
No formal recommendation provided.
As of 2026-01-19 • Updated nightlySource: Internal modelMethodology